An Exploratory Study to Evaluate Diagnostic Accuracy of a 7-day Adhesive Patch Electrocardiographic Monitoring for Detecting Arrhythmia in Patients With Palpitation.
Sponsor: HUINNO Co., Ltd
Trial Details
| Condition | Arrhythmia, Palpitations, Syncope |
| Intervention | MEMO Patch; 24-Hour Holter Monitor |
| Phase | NA |
| Status | Completed |
| Participants | 60 |
| Est. Completion | 29 July 2021 |
| Last Updated | 30 July 2026 |
Primary Outcome
Arrhythmia Detection
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Participants must meet all of the following criteria: 1. Adults aged 19 years or older who visit the study site during the study period with symptoms such as palpitations or syncope and are considered to require 24-hour ambulatory electrocardiographic monitoring. 2. Able and willing to provide voluntary written informed consent. 3. Able to wear the MEMO Patch™ continuously for 7 days. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: 1. A self-reported history of an allergic skin reaction to previously used adhesive products. 2. Planned electrical cardioversion, catheter ablation, or surgical treatment for an arrhythmia during the study period.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service